Carl Zeiss, Olympus enter licensing agreement for digital pathology patents
Carl Zeiss Microscopy (Jena, Germany) and Olympus America (Center Valley, PA) have entered into a nonexclusive worldwide licensing agreement that allows Carl Zeiss to access an extensive portfolio of patents held by Olympus in digital pathology and virtual microscopy. The patents included cover methods and equipment for creating, storing, and delivering virtual microscopy slides, enabling individuals to view and share high-resolution virtual microscopy images over the Internet.
"The handling of digital data has become a major driver of the development of modern microscopy,” says Dr. Bernhard Ohnesorge, Carl Zeiss Microscopy Board member and general manager, BioSciences Division. “Integrating the virtual slide functionality into our research microscope systems will enable our customers to become more efficient and to explore new scientific approaches. This will help them to better understand the root causes of the most challenging diseases.”
“Global adoption of digital slide scanning continues to expand into new medical and scientific applications,” says Brad Burklow, executive director business development, Scientific Equipment Group, Olympus Corporation of the Americas. “Olympus is the holder of many important patents in this area, and we feel it is vital to allow broad access to these technologies in order to advance the field of pathology and medical research. We are confident that leveraging these technologies will enhance healthcare for patients around the world.”
The companies are not making specific terms and conditions of the agreement public.
-----
Follow us on Twitter, 'like' us on Facebook, and join our group on LinkedIn
Follow Laser Focus World on your iPhone or Android
Subscribe now to BioOptics World magazine; it's free!